Sagility's US arm buys Chirok Health for up to $32.4M
What's the deal? SagilityDealroom has a profile for this one. Try Dealroom →'s wholly owned subsidiary, Sagility (US) Holdings, has agreed to acquire Chirok HealthDealroom has a profile for this one. Try Dealroom → for up to $32.35 million. The deal, signed on October 21, 2026, consists of $20 million upfront and up to $12.35 million tied to performance milestones. Sagility is buying 100% of the Tennessee-based company.
What each does: Chirok, founded in 2019, provides revenue cycle management, clinical documentation integrity, and medical coding services. Sagility operates in healthcare services and is adding Chirok's specialists to strengthen its provider-segment offering.
Why now? The purchase follows Sagility's June acquisition of CareSeedDealroom has a profile for this one. Try Dealroom →, which added HEDIS reporting and quality analytics for health plans, particularly in Medicare Advantage. Together, the deals mark a push from healthcare operations into broader payer services spanning documentation, coding, quality measurement, and care-gap work.
The numbers: Chirok reported turnover of $9 million for CY2025. For Sagility, the contingent portion of the price means part of the payout depends on future performance.
What could go wrong? The milestone-linked consideration ties $12.35 million to results Chirok has yet to deliver. The deal's value hinges on smooth integration and whether Sagility can turn the added expertise into client growth and cross-selling.
The signal: Two acquisitions in months show Sagility assembling an end-to-end payer-services stack, betting that documentation, coding, and quality analytics together will drive value-based care demand.
Read more: investywise.com
Image credit: Generated with Gemini
